Randomized phase II study of weekly docetaxel versus S-1 and concurrent radiotherapy for stage III and IV laryngeal, oropharyngeal, and hypopharyngeal cancer in elderly patients or patients with complications

Trial Profile

Randomized phase II study of weekly docetaxel versus S-1 and concurrent radiotherapy for stage III and IV laryngeal, oropharyngeal, and hypopharyngeal cancer in elderly patients or patients with complications

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Head and neck cancer; Laryngeal cancer; Oropharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top